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INTRODUCTION
Behcet's disease is a multi-system inflammatory
disorder with a chronic relapsing course. It is prevalent
along the ancient Silk Route.1 There are no patho-
gnomonic laboratory tests and the diagnosis requires
recurrent oral ulceration accompanied by two of the
following: genital ulceration, ocular disease, skin lesions
or a positive skin pathergy reaction.2,3 Despite the
inclusive criteria set forth by the International Study
Group, there are cases where the criteria cannot be met
and a diagnosis is missed. It usually affects young adults
20 – 40 years of age.4,5
We report, to the best of our knowledge, the first case
from Pakistan regarding an aggressive case of Behcet's
disease in a 39 years old man, with ocular manifestation
and venous thrombosis at multiple sites despite being on
anticoagulants.
CASE REPORT
A 39 years old man presented to the clinic with rash on
the body for 3 days. He complained of low grade
intermittent fever and left leg swelling since 4 – 5 days.
He was unable to swallow due to painful mouth ulcers
and hence was admitted. He was diagnosed to have
Behcet's disease 3 years ago and had been on warfarin.
In previous magnetic resonance imaging (MRI) and
magnetic resonance venography (MRV) repeated few
months after cerebral venous thrombosis superior
sagittal sinus was not clearly visualized in its posterior
part, with significantly increased vascularity noted in
the near vicinity of superior sagittal sinus. Features
were suggestive of partial re-canalization of superior
sagittal sinus following thrombosis (Figure 1). Magnetic
resonance arteriography (MRA) images were un-
remarkable. He developed recurrent mouth ulcers
progressively increasing in frequency with > 3 episodes
in a year. He was also treated with steroids during this
time. He gave a history of cigarette smoking 4 – 8/day.
Patient denied photosensitivity, alopecia, weight loss
and alcohol intake.
On examination, he was a lethargic man of good built,
afebrile with a blood pressure of 135/89 mmHg, pulse
rate 101 beats/minute and respiratory rate 19 breaths/
minute. There were multiple papulo-pustular 1 – 2 cm
lesions resembling acne on face, back, chest, groin and
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Figure 1:  Brain magnetic resonance venography (MRV) scan of our patient
with evident cerebral venous thrombosis on coronal and sagittal views: In
both MRV images, superior sagittal sinus is not clearly visualized with
significantly increased vascularity seen in near vicinity of superior sagittal
sinus. Imaging features are suggestive of partial re-canalization of superior
sagittal sinus following thrombosis.
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medial aspect of thighs and few were on the scrotum
too. Oral thrush with multiple apthous ulcers upto the
tonsillar pillars was seen. Left leg was swollen, red and
tender. His vision was blurred and was unable to read or
tell time. Fundoscopy revealed optic disc swelling in right
eye and macular oedema in left eye. At the site of the
cannula insertion a 2.5 mm erythematous papule was
noticed on the forearm. Systemic examination was
unremarkable.
Laboratory investigations are shown in Table I. Chest
X-ray was unremarkable. On Doppler ultrasound of left
leg the left external iliac, common femoral, superficial
femoral and popliteal veins appeared non-compressible,
distended and demonstrated no color filling or spectral
wave formation.  Behcet's Disease was confirmed as per
International Study Group (ISG) Criteria 1990.1 There
was evidence of venous thrombosis at multiple sites
(cerebral venous thrombosis and deep vein thrombosis
of left leg veins) along with disease relapse.
Enoxaparin 60 mg twice daily was overlapped with
warfarin 10 mg per day. Warfarin was gradually tapered
to 5 mg and continued on 5 mg daily at discharge. The
prothrombin time and international normalized ratio
(INR) monitoring showed subsequent INR to be
therapeutic 2.5 – 2.7. He was managed with antifungal
agents for his oral ulcers, and intravenous hydro-
cortisone for the disease relapse. His pustules started to
subside and no new eruptions were noticed during his
hospital stay. Azathioprine was also started on the
second day of admission as a steroid sparing agent.
Ophthalmology consult was sought and decreased
intraocular pressure in right eye and uveitis in the left
eye was affirmed. He was advised YAG laser and
intraretinal avastin for his left eye. A rheumatology
consult was taken and patient was offered infliximab to
salvage his vision. Patient refused to have treatment for
his vision and was discharged home.
DISCUSSION
We report this case of Behcet's disease with extensive
deep venous thrombosis along with thrombosis of the
cortical venous sinuses, a rare manifestation of this
disease from our part of the world. Arterial and venous
involvement is one of the characteristics of Behcet's
disease. Vascular involvement was seen in 8.3% cases
in Iran while 16.8% and 18% cases have been reported
from Turkey and Saudi Arabia respectively.6-8 Studies
report a fourteen-fold increase risk of venous thrombosis
in Behcet's patients.9 Venous involvement is common in
men especially those with ocular involvement and a
positive pathergy test.10
It is observed that men are more likely affected by
Behcet's disease. Age and gender distribution in India
shows a male to female ratio of 1.8 and the age of onset
is 33 years. These findings are corroborated in the
presently reported case and conforms to the data
available from the rest of the world. However the clinical
presentation reported from India shows involvement of
oral and apthous ulceration followed by joint and skin
involvement as opposed to clinical symptoms reported
from China and Iran where there was no significant joint
involvement.11
To conclude, ocular and cerebrovascular thrombosis are
important complications of Behcet's disease. These can
occur despite preemptive anticoagulation as provided
in the present case. Hence, there is a need for regular
follow-up of such cases.
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PT = Prothrombin time;  INR = International normalized ratio;  APTT = Activated partial
thromboplastin time;  ANA = Antinuclear antibody;  ASMA = Anti smooth muscle antibody;
AMA = Anti mitochondrial antibody.
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